“‘To Study The Association Of Leptin As A Predictive Marker In Obese And Non-Obese Women With Polycystic Ovary Syndrome Patients.’”, Journal of Pharmaceutical Negative Results, pp. 3930–3940, Dec. 2022, doi: 10.47750/pnr.2022.13.S08.495.